polymer coated oncolytic adenovirus therapy (Pharmicell/Hanyang University/University of Utah)

N/A

Report date: 2025/01/26 16:52:50

Base Information

Drug Namepolymer coated oncolytic adenovirus therapy (Pharmicell/Hanyang University/University of Utah)
Drug Alias NameN/A
ClassificationBiologics > Oncolytic virusCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Utah
China Registration ClassN/A

Develop Information

Active CompaniesFcb-PharmicellHanyang UniversityThe University Of Utah
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A